INCY
Incyte Corporation
NASDAQ · Healthcare · Biotechnology · US
$126.75
−0.98%0
Insider buys (3m)
21
Insider sells (3m)
-$15.7M
Net value (3m)
+24.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | Basi Ramitpal K · officer: EVP, Human Resources | F-InKind | 504 | $130 |
| Aug 20, 2026 | CAGNONI PABLO J · officer: President, Global Head of R&D | Sale | 10,801 | $126 |
| Aug 14, 2026 | CAGNONI PABLO J · officer: President, Global Head of R&D | Sale | 10,803 | $120 |
| Aug 7, 2026 | CAGNONI PABLO J · officer: President, Global Head of R&D | Sale | 10,640 | $123 |
| Aug 7, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,207 | $106 |
| Aug 7, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 2,207 | $124 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,918 | $61 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,284 | $64 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,072 | $72 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 2,293 | $119 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,864 | $78 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 3,148 | $69 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,623 | $75 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 6,055 | $120 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 326 | $105 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 4,695 | $119 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 6,055 | $105 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 9,459 | $72 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 1,642 | $119 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 2,187 | $119 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 85 | $122 |
| Aug 4, 2026 | CAGNONI PABLO J · officer: President, Global Head of R&D | Sale | 15,888 | $120 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 14,661 | $119 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 2,864 | $119 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,293 | $91 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 2,709 | $62 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 1,642 | $85 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 326 | $122 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | M-Exempt | 85 | $106 |
| Aug 4, 2026 | Mayes Patrick A · officer: EVP & Chief Scientific Officer | Sale | 5,332 | $119 |
Institutional positioning
13F filings over the trailing two quarters
New 233Increased 679Reduced 576Sold out 70
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Increased | 30,762,330 | Aug 14, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 30,744,412 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 18,978,198 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 18,032,718 | Aug 7, 2026 |
| DODGE & COX | Reduced | 12,252,356 | May 14, 2026 |
| DODGE & COX | Reduced | 11,957,326 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 11,024,289 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 10,930,066 | May 15, 2026 |
| STATE STREET CORP | Increased | 9,722,336 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 9,641,384 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 7,791,091 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 7,759,183 | May 8, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 5,807,930 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 5,320,901 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 4,750,735 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 27, 2026